Atlas FDA vs Nyquist Data
Nyquist Data positions itself around multi-country regulatory coverage - FDA plus agencies such as Japan's PMDA and China's NMPA - with AI search on top. For global submissions strategy it plays a different game than Atlas does.
Where Nyquist Data is strong
- Multi-country regulatory data in one place - valuable when your submission strategy spans the US, Japan, China and Europe
- AI-assisted search across international documents
- Enterprise support and onboarding
Where Atlas FDA is strong
- US 510(k) depth with joins the category rarely ships: recalls linked to the clearances they reference, review-time statistics computed per product code
- Public pricing and a genuinely free tier - no demo call to see the product
- Every record is a public, linkable page your whole team (and Google, and your AI assistant) can reach
- Predicate screening exports and client-ready reports in one click
Pricing
Nyquist's pricing is quote-based. Atlas: free tier, $29 Pro, $149 Business, published and self-serve.
| Nyquist Data | Atlas FDA | |
|---|---|---|
| Entry price | Quote-based | Free tier; $29/mo Pro |
| See it without a call | Demo-led | Every page public |
| Recall ↔ clearance cross-links | Varies | On every device page |
| Review-time stats per product code | Varies | Median + p90, public |
| API / MCP for AI assistants | Varies | Included every tier |
When to choose Nyquist Data
Choose Nyquist when multi-country coverage is the job. Choose Atlas when the job is US predicate research, FDA review-time evidence, and recall monitoring - done in minutes, at consultant-friendly prices.
We keep this comparison honest and current; if anything here is out of date, tell us at admin@atlasbyauro.com and we will fix it.
See Atlas for yourself - no demo needed
Browse the live data, run a predicate search, or grab a free API key.